WEST PHARMACEUTICAL SERVICES INC 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Mar 2, 2016
Insider Transaction Report
Form 4
ANDERSON MICHAEL A
Vice President & Treasurer
Transactions
- Exercise/Conversion
Common Stock
2016-03-01$16.05/sh+7,000$112,315→ 70,506.977 total - Exercise/Conversion
Common Stock
2016-03-01$22.48/sh+1,414$31,794→ 71,920.977 total - Sale
Common Stock
2016-03-01$63.60/sh−7,000$445,184→ 63,506.977 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-01$22.48/sh−1,414$31,794→ 0 totalExercise: $22.48From: 2008-02-27Exp: 2018-02-27→ Common Stock (1,414 underlying) - Sale
Common Stock
2016-03-01$63.66/sh−1,414$90,015→ 70,506.977 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-01$16.05/sh−7,000$112,315→ 0 totalExercise: $16.05From: 2010-02-24Exp: 2019-02-24→ Common Stock (7,000 underlying) - Sale
Common Stock
2016-03-01$63.56/sh−8,000$508,451→ 55,506.977 total
Holdings
- 915.484(indirect: By Savings Plan)
Common Stock
- 7,361.827(indirect: Non-Qualified Deferred Compensation Plan)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $63.50 to $63.63, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.